Report ID |
71284 |
Drug Identification Number |
02354586 |
Brand name |
RENVELA |
Common or Proper name |
Renvela |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
MARKETED |
Active Ingredient(s) |
Sevelamer Carbonate |
Strength(s) |
800MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL |
Packaging size |
180 |
ATC code |
V03AE |
ATC description |
ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage |
Delay in shipping of the drug. |
Anticipated start date |
|
Actual start date |
2019-01-03 |
Estimated end date |
2019-01-11 |
Actual end date |
2019-01-09 |
Shortage status |
Resolved |
Updated date |
2019-01-10 |
Company comments |
|
Health Canada comments |
|
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |